| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 3.33e-05 | 5 | 37 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.18e-04 | 12 | 37 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 2.57e-04 | 13 | 37 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 3.94e-04 | 16 | 37 | 2 | GO:0042043 | |
| GeneOntologyMolecularFunction | chloride ion binding | 3.94e-04 | 16 | 37 | 2 | GO:0031404 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 3.31e-06 | 2 | 38 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 9.90e-06 | 3 | 38 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 9.90e-06 | 3 | 38 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.98e-05 | 4 | 38 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | uterus development | 2.26e-05 | 30 | 38 | 3 | GO:0060065 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.17e-05 | 212 | 38 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 6.68e-05 | 119 | 38 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | gonadotrophin-releasing hormone neuronal migration to the hypothalamus | 6.90e-05 | 7 | 38 | 2 | GO:0021828 | |
| GeneOntologyBiologicalProcess | hypothalamic tangential migration using cell-axon interactions | 6.90e-05 | 7 | 38 | 2 | GO:0021856 | |
| GeneOntologyBiologicalProcess | courtship behavior | 6.90e-05 | 7 | 38 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | brainstem development | 9.19e-05 | 8 | 38 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 9.19e-05 | 8 | 38 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | hypothalamus cell migration | 1.18e-04 | 9 | 38 | 2 | GO:0021855 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron differentiation | 1.18e-04 | 9 | 38 | 2 | GO:0021886 | |
| GeneOntologyBiologicalProcess | hypothalamus gonadotrophin-releasing hormone neuron development | 1.18e-04 | 9 | 38 | 2 | GO:0021888 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.47e-04 | 10 | 38 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | cranial nerve formation | 1.80e-04 | 11 | 38 | 2 | GO:0021603 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.80e-04 | 11 | 38 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 1.93e-04 | 61 | 38 | 3 | GO:1902895 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 2.15e-04 | 161 | 38 | 4 | GO:0003231 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 2.55e-04 | 13 | 38 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 2.55e-04 | 13 | 38 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | central nervous system development | 2.56e-04 | 1197 | 38 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | hypothalamus cell differentiation | 2.97e-04 | 14 | 38 | 2 | GO:0021979 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 3.28e-04 | 73 | 38 | 3 | GO:2000630 | |
| GeneOntologyBiologicalProcess | male mating behavior | 3.42e-04 | 15 | 38 | 2 | GO:0060179 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 3.90e-04 | 16 | 38 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 3.94e-04 | 1269 | 38 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | heart development | 4.07e-04 | 757 | 38 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 4.79e-04 | 83 | 38 | 3 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 4.96e-04 | 84 | 38 | 3 | GO:0061614 | |
| GeneOntologyBiologicalProcess | neuron migration | 6.76e-04 | 218 | 38 | 4 | GO:0001764 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 7.32e-04 | 96 | 38 | 3 | GO:0048488 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 8.01e-04 | 99 | 38 | 3 | GO:0051145 | |
| GeneOntologyBiologicalProcess | brain development | 8.64e-04 | 859 | 38 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 8.73e-04 | 102 | 38 | 3 | GO:0140238 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 8.89e-04 | 24 | 38 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 8.99e-04 | 103 | 38 | 3 | GO:2000628 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell differentiation | 9.65e-04 | 25 | 38 | 2 | GO:2000725 | |
| GeneOntologyBiologicalProcess | circulatory system development | 9.95e-04 | 1442 | 38 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.12e-03 | 111 | 38 | 3 | GO:0036465 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.22e-03 | 911 | 38 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.26e-03 | 258 | 38 | 4 | GO:0001763 | |
| GeneOntologyBiologicalProcess | head development | 1.28e-03 | 919 | 38 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | forebrain neuron development | 1.39e-03 | 30 | 38 | 2 | GO:0021884 | |
| GeneOntologyBiologicalProcess | hypothalamus development | 1.49e-03 | 31 | 38 | 2 | GO:0021854 | |
| GeneOntologyBiologicalProcess | growth | 1.58e-03 | 1235 | 38 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | cranial nerve morphogenesis | 1.58e-03 | 32 | 38 | 2 | GO:0021602 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.03e-05 | 4 | 39 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 2.61e-04 | 13 | 39 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.61e-04 | 13 | 39 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | glycinergic synapse | 6.31e-04 | 20 | 39 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 9.12e-04 | 24 | 39 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.52e-03 | 31 | 39 | 2 | GO:0060077 | |
| MousePheno | abnormal uterus physiology | 4.24e-05 | 30 | 32 | 3 | MP:0009671 | |
| MousePheno | abnormal postimplantation uterine environment | 1.06e-04 | 7 | 32 | 2 | MP:0009669 | |
| Domain | RPEL_repeat | 2.70e-07 | 7 | 38 | 3 | IPR004018 | |
| Domain | RPEL | 2.70e-07 | 7 | 38 | 3 | PS51073 | |
| Domain | RPEL | 2.70e-07 | 7 | 38 | 3 | PF02755 | |
| Domain | RPEL | 2.70e-07 | 7 | 38 | 3 | SM00707 | |
| Domain | GREB1 | 4.03e-06 | 2 | 38 | 2 | PF15782 | |
| Domain | GREB1 | 4.03e-06 | 2 | 38 | 2 | IPR028422 | |
| Domain | NLGN4 | 4.03e-06 | 2 | 38 | 2 | IPR030025 | |
| Domain | - | 1.01e-05 | 21 | 38 | 3 | 1.10.720.30 | |
| Domain | SAP | 1.17e-05 | 22 | 38 | 3 | PF02037 | |
| Domain | SAP | 1.34e-05 | 23 | 38 | 3 | SM00513 | |
| Domain | SAP | 1.73e-05 | 25 | 38 | 3 | PS50800 | |
| Domain | SAP_dom | 1.73e-05 | 25 | 38 | 3 | IPR003034 | |
| Domain | PHD | 3.14e-05 | 89 | 38 | 4 | SM00249 | |
| Domain | Znf_PHD | 3.43e-05 | 91 | 38 | 4 | IPR001965 | |
| Domain | AWS | 4.02e-05 | 5 | 38 | 2 | PS51215 | |
| Domain | Nlgn | 4.02e-05 | 5 | 38 | 2 | IPR000460 | |
| Domain | AWS_dom | 4.02e-05 | 5 | 38 | 2 | IPR006560 | |
| Domain | AWS | 4.02e-05 | 5 | 38 | 2 | SM00570 | |
| Domain | ZF_PHD_2 | 4.06e-05 | 95 | 38 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 4.23e-05 | 96 | 38 | 4 | PS01359 | |
| Domain | SET | 7.85e-05 | 41 | 38 | 3 | PF00856 | |
| Domain | SET | 1.11e-04 | 46 | 38 | 3 | SM00317 | |
| Domain | SET_dom | 1.43e-04 | 50 | 38 | 3 | IPR001214 | |
| Domain | SET | 1.43e-04 | 50 | 38 | 3 | PS50280 | |
| Domain | Plexin_cytopl | 1.44e-04 | 9 | 38 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.44e-04 | 9 | 38 | 2 | IPR013548 | |
| Domain | Plexin | 1.44e-04 | 9 | 38 | 2 | IPR031148 | |
| Domain | Carboxylesterase_B_CS | 3.10e-04 | 13 | 38 | 2 | IPR019819 | |
| Domain | Zinc_finger_PHD-type_CS | 3.11e-04 | 65 | 38 | 3 | IPR019786 | |
| Domain | COesterase | 3.61e-04 | 14 | 38 | 2 | PF00135 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.61e-04 | 14 | 38 | 2 | PS00941 | |
| Domain | CarbesteraseB | 3.61e-04 | 14 | 38 | 2 | IPR002018 | |
| Domain | Post-SET_dom | 4.75e-04 | 16 | 38 | 2 | IPR003616 | |
| Domain | PostSET | 4.75e-04 | 16 | 38 | 2 | SM00508 | |
| Domain | POST_SET | 4.75e-04 | 16 | 38 | 2 | PS50868 | |
| Domain | IPT | 1.37e-03 | 27 | 38 | 2 | SM00429 | |
| Domain | TIG | 1.81e-03 | 31 | 38 | 2 | PF01833 | |
| Domain | SEMA | 1.81e-03 | 31 | 38 | 2 | PS51004 | |
| Domain | Sema | 1.81e-03 | 31 | 38 | 2 | SM00630 | |
| Domain | Semap_dom | 1.81e-03 | 31 | 38 | 2 | IPR001627 | |
| Domain | Sema | 1.81e-03 | 31 | 38 | 2 | PF01403 | |
| Domain | Plexin_repeat | 1.92e-03 | 32 | 38 | 2 | IPR002165 | |
| Domain | PSI | 1.92e-03 | 32 | 38 | 2 | PF01437 | |
| Domain | IPT | 1.92e-03 | 32 | 38 | 2 | IPR002909 | |
| Domain | Znf_FYVE_PHD | 3.29e-03 | 147 | 38 | 3 | IPR011011 | |
| Domain | PSI | 3.61e-03 | 44 | 38 | 2 | IPR016201 | |
| Domain | PSI | 3.94e-03 | 46 | 38 | 2 | SM00423 | |
| Domain | HMG_box | 5.20e-03 | 53 | 38 | 2 | PF00505 | |
| Domain | HMG_BOX_2 | 5.40e-03 | 54 | 38 | 2 | PS50118 | |
| Domain | HMG | 5.40e-03 | 54 | 38 | 2 | SM00398 | |
| Domain | - | 5.59e-03 | 55 | 38 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 7.73e-03 | 65 | 38 | 2 | IPR009071 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.67e-04 | 9 | 31 | 2 | MM15030 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 4.19e-04 | 14 | 31 | 2 | M7578 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 4.19e-04 | 14 | 31 | 2 | MM15029 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 4.83e-04 | 15 | 31 | 2 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 5.51e-04 | 16 | 31 | 2 | M8245 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 5.51e-04 | 16 | 31 | 2 | M16498 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17363709 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 37289107 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 17991879 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 12397177 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 16204380 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 18945672 | ||
| Pubmed | Muscle-specific signaling mechanism that links actin dynamics to serum response factor. | 1.30e-08 | 5 | 39 | 3 | 15798203 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 17360478 | ||
| Pubmed | Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function. | 3.70e-07 | 13 | 39 | 3 | 29114040 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28623279 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29106499 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 1.23e-06 | 2 | 39 | 2 | 24104404 | |
| Pubmed | MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants. | 1.23e-06 | 2 | 39 | 2 | 20338973 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23853104 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29335431 | ||
| Pubmed | Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations. | 1.23e-06 | 2 | 39 | 2 | 29100090 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 31928221 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26498848 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 1.23e-06 | 2 | 39 | 2 | 32243781 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12944485 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22989184 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 18434543 | ||
| Pubmed | Myocardin-related transcription factors are required for skeletal muscle development. | 1.23e-06 | 2 | 39 | 2 | 27385017 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14970199 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23183221 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24855039 | ||
| Pubmed | Myocardin-related transcription factors are required for cardiac development and function. | 1.23e-06 | 2 | 39 | 2 | 26386146 | |
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 1.23e-06 | 2 | 39 | 2 | 37001827 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17714703 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28739660 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 1.23e-06 | 2 | 39 | 2 | 37080762 | |
| Pubmed | Myocardin related transcription factors are required for coordinated cell cycle progression. | 1.23e-06 | 2 | 39 | 2 | 23656782 | |
| Pubmed | Myocardin regulates BMP10 expression and is required for heart development. | 1.47e-06 | 20 | 39 | 3 | 22996691 | |
| Pubmed | 1.98e-06 | 22 | 39 | 3 | 25516967 | ||
| Pubmed | 2.60e-06 | 24 | 39 | 3 | 30796970 | ||
| Pubmed | 2.95e-06 | 25 | 39 | 3 | 20019329 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18628683 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22139079 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 8806646 | ||
| Pubmed | Role of CRP2-MRTF interaction in functions of myofibroblasts. | 3.67e-06 | 3 | 39 | 2 | 37164693 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 26024305 | ||
| Pubmed | MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation. | 3.67e-06 | 3 | 39 | 2 | 22806889 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 32011705 | ||
| Pubmed | Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke. | 3.67e-06 | 3 | 39 | 2 | 26221020 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18025109 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23103763 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 19198601 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 14565952 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11439182 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 3.67e-06 | 3 | 39 | 2 | 21282647 | |
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 3.67e-06 | 3 | 39 | 2 | 11241833 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20138877 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 29716942 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17947237 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18056415 | ||
| Pubmed | 5.18e-06 | 30 | 39 | 3 | 29555813 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16077734 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17292328 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 7.34e-06 | 4 | 39 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 7.34e-06 | 4 | 39 | 2 | 22671294 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 24758171 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20579107 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10725340 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 11306810 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 28729363 | ||
| Pubmed | Nuclear RhoA signaling regulates MRTF-dependent SMC-specific transcription. | 7.34e-06 | 4 | 39 | 2 | 24906914 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 35216178 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 7.34e-06 | 4 | 39 | 2 | 25518740 | |
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 7.34e-06 | 4 | 39 | 2 | 8570614 | |
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 1.07e-05 | 38 | 39 | 3 | 27930960 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.22e-05 | 5 | 39 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.22e-05 | 5 | 39 | 2 | 10996085 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 25313870 | ||
| Pubmed | Differential regulation of hair cell actin cytoskeleton mediated by SRF and MRTFB. | 1.22e-05 | 5 | 39 | 2 | 37982489 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 23764775 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 39390582 | ||
| Pubmed | Sarcomeres regulate murine cardiomyocyte maturation through MRTF-SRF signaling. | 1.22e-05 | 5 | 39 | 2 | 33361330 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 37865312 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 21838267 | ||
| Pubmed | Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice. | 1.83e-05 | 6 | 39 | 2 | 29100091 | |
| Pubmed | Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. | 1.83e-05 | 6 | 39 | 2 | 23563308 | |
| Pubmed | MRTF-SRF signaling is required for seeding of HSC/Ps in bone marrow during development. | 1.83e-05 | 6 | 39 | 2 | 25573994 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 29724786 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17183527 | ||
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 1.83e-05 | 6 | 39 | 2 | 24019522 | |
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 1.83e-05 | 6 | 39 | 2 | 19480842 | |
| Pubmed | Temporal control of PDGFRα regulates the fibroblast-to-myofibroblast transition in wound healing. | 2.56e-05 | 7 | 39 | 2 | 35977484 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 2.56e-05 | 7 | 39 | 2 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 2.56e-05 | 7 | 39 | 2 | 19655386 | |
| Pubmed | Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. | 2.56e-05 | 7 | 39 | 2 | 10520994 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 38713765 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 15661641 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 3.42e-05 | 8 | 39 | 2 | 30871858 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 3.42e-05 | 8 | 39 | 2 | 22368082 | |
| Pubmed | PlexinA2 and semaphorin signaling during cardiac neural crest development. | 4.39e-05 | 9 | 39 | 2 | 11688557 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 23010509 | ||
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 19909241 | ||
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 4.39e-05 | 9 | 39 | 2 | 29252214 | |
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 5.48e-05 | 10 | 39 | 2 | 18804103 | |
| Interaction | RCOR1 interactions | 3.33e-05 | 494 | 38 | 7 | int:RCOR1 | |
| Interaction | KDM1A interactions | 4.87e-05 | 941 | 38 | 9 | int:KDM1A | |
| Interaction | NCOA3 interactions | 6.04e-05 | 224 | 38 | 5 | int:NCOA3 | |
| Interaction | SEMA5A interactions | 7.23e-05 | 7 | 38 | 2 | int:SEMA5A | |
| GeneFamily | Plexins | 5.06e-05 | 9 | 22 | 2 | 683 | |
| GeneFamily | PHD finger proteins | 1.72e-04 | 90 | 22 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.74e-04 | 34 | 22 | 2 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.02e-02 | 718 | 22 | 4 | 28 | |
| GeneFamily | Immunoglobulin like domain containing | 2.28e-02 | 193 | 22 | 2 | 594 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.86e-07 | 179 | 39 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.42e-07 | 183 | 39 | 5 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.41e-07 | 200 | 39 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.41e-07 | 200 | 39 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.41e-07 | 200 | 39 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.41e-07 | 200 | 39 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.41e-07 | 200 | 39 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.41e-07 | 200 | 39 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-05 | 176 | 39 | 4 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-05 | 177 | 39 | 4 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 178 | 39 | 4 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-05 | 182 | 39 | 4 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-05 | 183 | 39 | 4 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-05 | 184 | 39 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.99e-05 | 184 | 39 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-05 | 184 | 39 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 185 | 39 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.03e-05 | 185 | 39 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.03e-05 | 185 | 39 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.03e-05 | 185 | 39 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-05 | 185 | 39 | 4 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-05 | 186 | 39 | 4 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.12e-05 | 187 | 39 | 4 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.17e-05 | 188 | 39 | 4 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 188 | 39 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 189 | 39 | 4 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-05 | 190 | 39 | 4 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.26e-05 | 190 | 39 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-05 | 192 | 39 | 4 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 2.35e-05 | 192 | 39 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 39 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 39 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 39 | 4 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 39 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 39 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.40e-05 | 193 | 39 | 4 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 194 | 39 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 194 | 39 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 194 | 39 | 4 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-05 | 195 | 39 | 4 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 2.55e-05 | 196 | 39 | 4 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-05 | 198 | 39 | 4 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.71e-05 | 199 | 39 | 4 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 2.71e-05 | 199 | 39 | 4 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-GXYLT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | fe63aa1febd2bf650a7dd4e8b4420063580644ba | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 3ece392f336547aea7dea625d9102819b04b4f7a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-GXYLT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 37728d83b246dd70933d1f52f938bc1c401df7b9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | e9b5105fff7845a98f962d609c2055528583b48e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-GXYLT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | cafa1b46d0b052fca6191ad99d5862a07d0a1fd2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.76e-05 | 200 | 39 | 4 | fa0d4a0c93b0b0ad0331e7b7013373be27958c4e | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 112 | 39 | 3 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | (05)_Ciliated-(2)_48hpi|(05)_Ciliated / shred by cell type and Timepoint | 1.74e-04 | 124 | 39 | 3 | fc8cce8c1809edafbc4e69e501dd4f016f5dfc0b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.18e-04 | 134 | 39 | 3 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 146 | 39 | 3 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 152 | 39 | 3 | eee86b508b8f140ea44e21d8c04c409a7b689e39 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-04 | 154 | 39 | 3 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | -Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-04 | 156 | 39 | 3 | f0c4d9d58365b0ae8e10ba1aaf3847fb3f98c7ad | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 158 | 39 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 158 | 39 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 159 | 39 | 3 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-04 | 159 | 39 | 3 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-04 | 165 | 39 | 3 | 6a621b300442c52adfc15b61d3a6d3a3cb00099f | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.31e-04 | 169 | 39 | 3 | 6fe82db874eff0f86e5c0d1cc81322eb9d7874eb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.31e-04 | 169 | 39 | 3 | e3100eb587005e160bd0b7990fa57ec49765133d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-04 | 169 | 39 | 3 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.38e-04 | 170 | 39 | 3 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-04 | 170 | 39 | 3 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-04 | 170 | 39 | 3 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 4.46e-04 | 171 | 39 | 3 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-04 | 171 | 39 | 3 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.53e-04 | 172 | 39 | 3 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-04 | 172 | 39 | 3 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-04 | 172 | 39 | 3 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 4.53e-04 | 172 | 39 | 3 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.69e-04 | 174 | 39 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 174 | 39 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 174 | 39 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-04 | 174 | 39 | 3 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-04 | 174 | 39 | 3 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-04 | 174 | 39 | 3 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-04 | 175 | 39 | 3 | 29a4197ad4b2382257d7cc9ff237726bb60bc06d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-04 | 176 | 39 | 3 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 4.85e-04 | 176 | 39 | 3 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.85e-04 | 176 | 39 | 3 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 4.85e-04 | 176 | 39 | 3 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.93e-04 | 177 | 39 | 3 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.93e-04 | 177 | 39 | 3 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 4.93e-04 | 177 | 39 | 3 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.01e-04 | 178 | 39 | 3 | a28683690ab8a60eb18f3ef87ea85da4e95b22df | |
| Disease | 2-hydroxystearate measurement | 5.78e-05 | 9 | 38 | 2 | EFO_0021059 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.91e-04 | 152 | 38 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.28e-03 | 41 | 38 | 2 | DOID:10584 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.11e-03 | 713 | 38 | 5 | EFO_0005689 | |
| Disease | uterine fibroid | 2.14e-03 | 199 | 38 | 3 | EFO_0000731 | |
| Disease | antisaccade response measurement | 2.38e-03 | 56 | 38 | 2 | EFO_0006874 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.46e-03 | 57 | 38 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.55e-03 | 447 | 38 | 4 | C3714756 | |
| Disease | creatine kinase measurement | 2.64e-03 | 59 | 38 | 2 | EFO_0004534 | |
| Disease | hypertension, white matter hyperintensity measurement | 2.91e-03 | 62 | 38 | 2 | EFO_0000537, EFO_0005665 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 3.79e-03 | 71 | 38 | 2 | EFO_0004735, EFO_0007965 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPKYSPYNKLQKTAH | 301 | Q9H6B1 | |
| KHNQLYKKPDVPLYK | 2061 | Q9NR48 | |
| LLNLPPKKKNADYYE | 2471 | Q9NR48 | |
| LLVYKKHKEYNPIEN | 516 | Q14956 | |
| KQKYNLQLKYPHLPC | 311 | Q9UL18 | |
| AKPPKKSYVNYKVLQ | 201 | Q8NDD1 | |
| LQDHVKKSTAPYKYP | 536 | P0C7M7 | |
| YRKLALKYHPDKNPN | 26 | P31689 | |
| QFLKDYFHKKPYPSK | 1056 | Q6IQ32 | |
| YYPEHCLPKKKPKLK | 1706 | Q7Z5J4 | |
| KHPQIQKKSQYIKYL | 471 | Q70E73 | |
| YKLHLKNNKLEKIPP | 241 | Q7Z5L7 | |
| TQPKKQKHLKYYLVR | 181 | Q4ZG55 | |
| VQPKYKHVYPKNSVV | 356 | A8MXV4 | |
| YQQKPDQAPKLLIKY | 56 | A0A0C4DH26 | |
| QYKFYDPPPKKKNHW | 1391 | Q9P219 | |
| PSNKLLYAKDIPNYK | 1796 | Q9UIW2 | |
| PSNKLLYAKDIPNYK | 1771 | P51805 | |
| QIPYNNKLIHIKKYG | 556 | Q7Z5P9 | |
| YKHIKVNKPYGKVQI | 991 | O96028 | |
| KPRVKKLKYHQYIPP | 286 | Q9ULH7 | |
| YQNCKKKLGKLPPQY | 216 | P00973 | |
| TTQPKKQKHLKYYLV | 206 | Q9C091 | |
| PKPKVKKLKYHQYIP | 256 | Q8IZQ8 | |
| KKLKYHQYIPPDQKA | 261 | Q8IZQ8 | |
| KYNPKDQLYLHIGLK | 561 | Q8NFZ3 | |
| IFKQLPKKLYPEYHK | 341 | Q9Y236 | |
| HLDEKIKLYNQKYPG | 231 | Q9NY28 | |
| VKNPPAAYIQKLKSY | 76 | O95466 | |
| SYKKKQPYAQHQPLS | 666 | O00237 | |
| KYNPKDQLYLHIGLK | 561 | Q8N0W4 | |
| LYKIHPQYPKRLHKV | 416 | Q2TB90 | |
| YDEKNLKIKPFYCPH | 691 | Q149N8 | |
| PNKKNSYPHYVKSIV | 26 | P03915 | |
| TLPYPLKKQNGKIKY | 561 | O75626 | |
| PKVKKLKYHQYIPPD | 231 | Q969V6 | |
| YKEKKKYQPKPAVAH | 506 | Q8WXE9 | |
| HLEKYPNYKYKPRPK | 681 | P35712 | |
| LKYYVLNALKHRPPK | 451 | Q6P2Q9 | |
| YHFKPKKIKTKDLFP | 981 | Q13129 | |
| IKSKKLLYKPVNHYE | 476 | Q02763 | |
| QGKPFKAKYKLVNHI | 181 | Q8N9L1 | |
| HYYPENVKPKPKLKE | 381 | P82987 |